Who to call at ImageneBio, Inc., and when
Fundz watches for the moments ImageneBio, Inc. starts buying, and tells you who to reach.
- An alert the day ImageneBio, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ImageneBio, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ImageneBio, Inc.. With Fundz connected, it knows.
ImageneBio, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
inmagenebio.comAI Executive Summary
AI-powered analysis of 8-K filing content
On October 21, 2025, ImageneBio's board appointed CEO Kristin Yarema, Ph.D., as interim principal financial officer, effective immediately. The concentration of CEO and CFO-equivalent duties in one executive is a notable governance change that bears on financial oversight.
Key Takeaways
Dr. Kristin Yarema, the Company's CEO, was appointed interim principal financial officer by the board effective October 21, 2025.
The filing does not name a permanent principal financial officer or state whether a search is underway.
2 more takeaways
Related Filings (11)
11 more filings from ImageneBio, Inc. in the last 90 days
Filing Overview
What This Means
ImageneBio, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.